NOTR:OTC-Nowtransit Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 13

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
ALBHF Alibaba Health Information Tec..

N/A

USD 7.22B
RADLY Raia Drogasil SA ADR

N/A

USD 6.95B
CLCGY Clicks Group Ltd

+0.52 (+1.39%)

USD 3.99B
SAEYY Shop Apotheke Europe N.V

+0.86 (+7.60%)

USD 2.48B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.28B
ZRSEF Zur Rose Group AG

N/A

USD 1.12B
NVACF Nova Cannabis Inc

-0.03 (-2.85%)

USD 0.05B
RADCQ Rite Aid Corporation

+0.02 (+113.33%)

USD 0.01B
RXMD Progressive Care Inc

+0.12 (+7.62%)

USD 8.74M
HEWA Healthwarehouse.Com

N/A

USD 6.97M

ETFs Containing NOTR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 81.90% 72% C 82% B
Dividend Return 81.90% 72% C 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 107.76% 48% F 32% F
Risk Adjusted Return 76.00% 100% F 96% N/A
Market Capitalization 0.04B 73% C 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.